Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950135-07-000818
Filing Date
2007-02-14
Accepted
2007-02-14 10:36:08
Documents
1
Group Members
NOVARTIS AG

Document Format Files

Seq Description Document Type Size
1 NOVARTIS PHARMA AG RE: INFINITY PHARMACEUTICALS, INC. b64155npsc13g.htm SC 13G 68545
  Complete submission text file 0000950135-07-000818.txt   70633
Mailing Address LICHTSTRASSE 35 CH-4002 BASEL V8
Business Address LICHTSTRASSE 35 CH-4002 BASEL V8 212-830-2474
NOVARTIS PHARMA AG (Filed by) CIK: 0001030617 (see all company filings)

Type: SC 13G

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

EIN.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60943 | Film No.: 07614555
SIC: 2834 Pharmaceutical Preparations